arrow
P

Peter Coyle

Hamad Medical Corporation
H指数:67
被引数:1.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Evaluating COVID-19 vaccine effectiveness across epidemiologic designs: test-negative case-control versus retrospective cohort analyses in a nationwide study

评估COVID-19疫苗在不同流行病学设计中的有效性:一项全国性研究中测试阴性病例对照分析与回顾性队列分析的比较

2026-09-220
OAAI
Palivizumab for respiratory syncytial virus immunoprophylaxis in high-risk populations in Qatar: a call for action

帕利珠单抗在卡塔尔高危人群中预防呼吸道合胞病毒感染的免疫预防作用:一项行动呼吁

2026-07-270
PRE
Expert opinion on improving influenza vaccination coverage rate in Qatar: Strategic solutions and role of live attenuated influenza vaccine (LAIV)

关于提高卡塔尔流感疫苗接种覆盖率的专业意见:战略解决方案与减毒活流感疫苗(LAIV)的作用

2026-02-120
OA
Estimating SARS-CoV-2 infection incidence and detection rates: Demonstrating a novel surveillance method

估计SARS-CoV-2感染发病率和检测率:展示一种新型监测方法

2025-10-290
OAAI
Evaluating the cost-effectiveness of COVID-19 mRNA primary-series vaccination in Qatar: An integrated epidemiological and economic analysis

评估卡塔尔COVID-19 mRNA基础系列疫苗接种的成本效益:一项整合流行病学和经济学的分析

2025-09-260
PRE
Successfully addressing non-compliance with behavioral and social infection control measures is a critical component in management of healthcare worker COVID-19 outbreaks: learning outcomes from the first staff outbreak in the main maternity hospital in Qatar

成功应对行为和社会感染控制措施的不合规行为是管理医疗工作者COVID-19疫情的关键组成部分:来自卡塔尔主要产院首次员工疫情的学习成果

2025-09-010
OA
Comparative effectiveness of one versus two doses of COVID-19 vaccines in Qatar: Evidence of converging protection over time

卡塔尔关于COVID-19疫苗一剂与两剂比较有效性的研究:证据显示保护效果随时间趋同

Vaccine
IF3.5
2025-07-290
OA
Prevalence of hepatitis C virus infection in Qatar's resident population based on a national screening campaign

基于全国筛查运动卡塔尔居民人口中丙型肝炎病毒感染的患病率

2025-04-180
OA
Protection conferred by SARS-CoV-2 infection across a spectrum of reinfection symptoms and severities
2025-03-260
OAAI
Evaluating Hospital Admission Data as Indicators of COVID-19 Severity: A National Assessment in Qatar

以住院数据为指标评估新型冠状病毒肺炎严重程度:卡塔尔全国评估

2025-02-170
OAAI
BNT162b2 Versus mRNA-1273 Vaccines: Comparative Analysis of Long-Term Protection Against SARS-CoV-2 Infection and Severe COVID-19 in Qatar

BNT162b2与mRNA-1273疫苗: 卡塔尔长期预防SARS-CoV-2感染和严重新型冠状病毒肺炎的比较分析

2024-09-290
OA
Prevalence of hepatitis B and C viruses among migrant workers in Qatar

卡塔尔移民工人中乙型和丙型肝炎病毒的患病率

2024-05-176
OAAI
Protection of natural infection against reinfection with SARS-CoV-2 JN.1 variant

保护自然感染免受SARS-CoV-2 JN.1变体的再感染

2024-04-095
OAAI
Addressing bias in the definition of SARS-CoV-2 reinfection: implications for underestimation

解决SARS-CoV-2再感染定义中的偏见: 低估的含义

2024-03-114
OAAI
Estimating protection afforded by prior infection in preventing reinfection: applying the test-negative study design

评估先前感染对预防再感染的保护作用: 应用测试阴性研究设计

2023-12-077
OAAI
SARS-CoV-2 infection and effects of age, sex, comorbidity, and vaccination among older individuals: A national cohort study
2023-11-211
OA